Our services
P4 Phase IV (Interventional)
PE Post-Authorization Efficacy Study (PAES)
PS Post-Authorization Safety Study (PASS)
AC Expanded Access & Compassionate Use
OP Observational Prospective Study
OR Observational Retrospective Study
RE Patient Registries
PS Pharmaceopidemilogical Study
DU Drug Utilization Research
MR Pricing and Market Access research
CC Case Control Study
  • Provided directly by KCR
  • Provided by Preferred Providers
lp

We design and execute late phase studies to support positioning our clients’ medical products in successful market entry. KCR offers an innovative and flexible approach to late phase projects thanks to robust technology coupled with well-designed processes. Our goal is to assure the client’s post-approval success in both scientific and commercial aspects.  

We focus on applicable solutions and work towards the best results.

Therapeutic Areas:

  • Cardiovascular
  • Dermatology
  • Endoctrinology
  • Gastrointestinal
  • Healthy subjects
  • Hematology
  • Immunology
  • Infectious Diseases
  • Nephrology
  • Neurology
  • Oncology
  • Ophtalmology
  • Orthopedics
  • Otorhinolaryngology
  • Psychiatry
  • Respiratory
  • Rheumatology
  • Surgery
  • Transplantology
  • Urology
  • Women's Health

Contact Us